In breast cancer, this decrease of DDR1 expression has been linked to the increase of ZEB1 expression, which is involved in EMT, and which has been identified has a transcriptional repressor of DDR1 expression (Koh et al., 2015). Here, DDR1 is linked to breast carcinoma.